| - GRCh37:
- Chr17:4857154
- GRCh38:
- Chr17:4953859
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856643
- GRCh38:
- Chr17:4953348
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860276
- GRCh38:
- Chr17:4956981
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4855130
- GRCh38:
- Chr17:4951835
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858911
- GRCh38:
- Chr17:4955616
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860148
- GRCh38:
- Chr17:4956853
| ENO3 | R400H, R357H, R409H | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858603
- GRCh38:
- Chr17:4955308
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857048
- GRCh38:
- Chr17:4953753
| ENO3 | V118M, V75M, V127M | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856626
- GRCh38:
- Chr17:4953331
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858835
- GRCh38:
- Chr17:4955540
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859248
- GRCh38:
- Chr17:4955953
| ENO3 | E250K, E293K, E302K | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858836
- GRCh38:
- Chr17:4955541
| ENO3 | A225T, A268T, A277T | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856139
- GRCh38:
- Chr17:4952844
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858481
- GRCh38:
- Chr17:4955186
| ENO3 | A143T, A186T, A195T | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856339
- GRCh38:
- Chr17:4953044
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858792
- GRCh38:
- Chr17:4955497
| ENO3 | R210H, R253H, R262H | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858538
- GRCh38:
- Chr17:4955243
| ENO3 | T214A, T162A, T205A | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857047
- GRCh38:
- Chr17:4953752
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858449
- GRCh38:
- Chr17:4955154
| ENO3 | A184V, A175V, A132V | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860340
- GRCh38:
- Chr17:4957045
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858880
- GRCh38:
- Chr17:4955585
| ENO3 | S282R, S239R, S291R | Inborn genetic diseases, Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:4857108
- GRCh38:
- Chr17:4953813
| ENO3 | A138P, A147P, A95P | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856588
- GRCh38:
- Chr17:4953293
| ENO3 | E88*, E97* | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856420
- GRCh38:
- Chr17:4953125
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860323
- GRCh38:
- Chr17:4957028
| ENO3 | R386H, R429H, R438H | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858582
- GRCh38:
- Chr17:4955287
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860130
- GRCh38:
- Chr17:4956835
| ENO3 | K394R, K351R, K403R | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858863
- GRCh38:
- Chr17:4955568
| ENO3 | G234R, G277R, G286R | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858472
- GRCh38:
- Chr17:4955177
| ENO3 | R183C, R192C, R140C | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858447
- GRCh38:
- Chr17:4955152
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858587
- GRCh38:
- Chr17:4955292
| ENO3 | N230S, N221S, N178S | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860333
- GRCh38:
- Chr17:4957038
| ENO3 | K389N, K432N, K441N | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856399
- GRCh38:
- Chr17:4953104
| ENO3 | Q79*, Q88* | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860294
- GRCh38:
- Chr17:4956999
| ENO3 | D419E, D428E, D376E | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860273
- GRCh38:
- Chr17:4956978
| ENO3 | R369S, R412S, R421S | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856135
- GRCh38:
- Chr17:4952840
| ENO3 | Y44C, Y53C | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857080
- GRCh38:
- Chr17:4953785
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Dec 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856375-4856376
- GRCh38:
- Chr17:4953080-4953081
| ENO3 | N71G, N80G | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857090
- GRCh38:
- Chr17:4953795
| ENO3 | R132C, R141C, R89C | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857145
- GRCh38:
- Chr17:4953850
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860170
- GRCh38:
- Chr17:4956875
| ENO3 | Y364*, Y416*, Y407* | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856624
- GRCh38:
- Chr17:4953329
| ENO3 | T109S, T100S | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858488
- GRCh38:
- Chr17:4955193
| ENO3 | V145A, V188A, V197A | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860277
- GRCh38:
- Chr17:4956982
| ENO3 | E371K, E414K, E423K | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858357
- GRCh38:
- Chr17:4955062
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856099
- GRCh38:
- Chr17:4952804
| ENO3 | R32Q, R41Q | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858778
- GRCh38:
- Chr17:4955483
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858805
- GRCh38:
- Chr17:4955510
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858548
- GRCh38:
- Chr17:4955253
| ENO3 | G165A, G208A, G217A | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857079
- GRCh38:
- Chr17:4953784
| ENO3 | V137D, V85D, V128D | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860152
- GRCh38:
- Chr17:4956857
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859895
- GRCh38:
- Chr17:4956600
| ENO3 | W322*, W365*, W374* | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860126
- GRCh38:
- Chr17:4956831
| ENO3 | I350V, I393V, I402V | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860182
- GRCh38:
- Chr17:4956887
| ENO3 | M411I, M368I, M420I | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858393
- GRCh38:
- Chr17:4955098
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857147
- GRCh38:
- Chr17:4953852
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856078
- GRCh38:
- Chr17:4952783
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858394
- GRCh38:
- Chr17:4955099
| ENO3 | S166A, S114A, S157A | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860164
- GRCh38:
- Chr17:4956869
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856188-4856190
- GRCh38:
- Chr17:4952893-4952895
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857141
- GRCh38:
- Chr17:4953846
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858456
- GRCh38:
- Chr17:4955161
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858543
- GRCh38:
- Chr17:4955248
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858426
- GRCh38:
- Chr17:4955131
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859439
- GRCh38:
- Chr17:4956144
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858495
- GRCh38:
- Chr17:4955200
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860127
- GRCh38:
- Chr17:4956832
| ENO3 | I350S, I393S, I402S | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859297
- GRCh38:
- Chr17:4956002
| ENO3 | S309L, S266L, S318L | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856092
- GRCh38:
- Chr17:4952797
| ENO3 | R30*, R39* | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859285
- GRCh38:
- Chr17:4955990
| ENO3 | T314I, T262I, T305I | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4855180
- GRCh38:
- Chr17:4951885
| ENO3 | T19M, T28M | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858564
- GRCh38:
- Chr17:4955269
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859340
- GRCh38:
- Chr17:4956045
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856373
- GRCh38:
- Chr17:4953078
| ENO3 | N70S, N79S | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858806
- GRCh38:
- Chr17:4955511
| ENO3 | D258Y, D215Y, D267Y | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858760
- GRCh38:
- Chr17:4955465
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856096
- GRCh38:
- Chr17:4952801
| ENO3 | F31Y, F40Y | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860189
- GRCh38:
- Chr17:4956894
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4860203
- GRCh38:
- Chr17:4956908
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4855158
- GRCh38:
- Chr17:4951863
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4855127
- GRCh38:
- Chr17:4951832
| ENO3 | M10I, M1I | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859302
- GRCh38:
- Chr17:4956007
| ENO3 | V268L, V311L, V320L | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856581
- GRCh38:
- Chr17:4953286
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858387
- GRCh38:
- Chr17:4955092
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4857153
- GRCh38:
- Chr17:4953858
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859224
- GRCh38:
- Chr17:4955929
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856422
- GRCh38:
- Chr17:4953127
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858489
- GRCh38:
- Chr17:4955194
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856109
- GRCh38:
- Chr17:4952814
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859229
- GRCh38:
- Chr17:4955934
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856328
- GRCh38:
- Chr17:4953033
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858498
- GRCh38:
- Chr17:4955203
| ENO3 | H191Q, H200Q, H148Q | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858359
- GRCh38:
- Chr17:4955064
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859915
- GRCh38:
- Chr17:4956620
| ENO3 | R329H, R372H, R381H | Glycogen storage disease due to muscle beta-enolase deficiency, Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:4858696
- GRCh38:
- Chr17:4955401
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4856201
- GRCh38:
- Chr17:4952906
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859992
- GRCh38:
- Chr17:4956697
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859873
- GRCh38:
- Chr17:4956578
| ENO3 | K315I, K358I, K367I | Glycogen storage disease due to muscle beta-enolase deficiency | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4859222
- GRCh38:
- Chr17:4955927
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4858540
- GRCh38:
- Chr17:4955245
| ENO3 | | Glycogen storage disease due to muscle beta-enolase deficiency | Likely benign (Mar 11, 2022) | criteria provided, single submitter |